Z-L-glutamine
Need Assistance?
  • US & Canada:
    +
  • UK: +

Z-L-glutamine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
CBZ-Amino Acids
Catalog number
BAT-003349
CAS number
2650-64-8
Molecular Formula
C13H16N2O5
Molecular Weight
280.30
Z-L-glutamine
IUPAC Name
(2S)-5-amino-5-oxo-2-(phenylmethoxycarbonylamino)pentanoic acid
Synonyms
Z-L-Gln-OH; N-Carbobenzoxy-L-Glutamine
Appearance
White to off-white powder
Purity
≥ 98% (HPLC)
Density
1.2419 g/cm3(rough estimate)
Melting Point
130-138 °C
Boiling Point
423°C (rough estimate)
Storage
Store at 2-8 °C
InChI
InChI=1S/C13H16N2O5/c14-11(16)7-6-10(12(17)18)15-13(19)20-8-9-4-2-1-3-5-9/h1-5,10H,6-8H2,(H2,14,16)(H,15,19)(H,17,18)/t10-/m0/s1
InChI Key
JIMLDJNLXLMGLX-JTQLQIEISA-N
Canonical SMILES
C1=CC=C(C=C1)COC(=O)NC(CCC(=O)N)C(=O)O

Z-L-glutamine is a derivative of the amino acid L-glutamine, in which the α-amino group is protected by a carbobenzoxy (Z) group. This protection prevents the amino group from participating in unwanted side reactions during chemical synthesis, making it a valuable intermediate for various biochemical processes. Glutamine itself is an important amino acid involved in protein synthesis, metabolism, and cellular functions. The Z-protection of the amino group enables the selective manipulation of other reactive sites on the molecule.

One key application of Z-L-glutamine is in solid-phase peptide synthesis (SPPS). In SPPS, peptides are synthesized step by step on a solid support, and Z-L-glutamine is used as a building block for incorporating glutamine into peptides. The Z group ensures that the α-amino group remains protected during the synthesis process, preventing premature reactions and facilitating the assembly of longer peptide sequences. This makes Z-L-glutamine an essential reagent for creating peptides with specific sequences containing glutamine residues.

Another significant application of Z-L-glutamine is in the design of glutamine analogs for pharmaceutical research. By modifying the structure of glutamine, researchers can develop compounds that mimic its biological activity but with altered properties. These glutamine analogs can be used to explore new therapeutic strategies, particularly in areas like cancer, neurological disorders, and metabolic diseases. The Z-protection of the amino group allows for selective functionalization of other sites, facilitating the creation of diverse analogs that could have enhanced bioactivity or stability.

Z-L-glutamine is also used in the development of peptide-based drug delivery systems. The Z group helps protect the amino functionality during conjugation reactions, allowing for the creation of stable drug conjugates. These conjugates can be designed to target specific cells or tissues, improving the precision of drug delivery. This targeted approach is particularly valuable in cancer therapy, where delivering drugs directly to tumor cells while minimizing exposure to healthy tissue is crucial. Z-L-glutamine’s reactivity and stability make it a useful component in such targeted therapies.

Lastly, Z-L-glutamine is employed in the synthesis of peptidomimetics, which are non-peptide molecules designed to mimic the biological functions of peptides. These mimetics often exhibit improved stability, bioavailability, and resistance to enzymatic degradation compared to natural peptides. The Z-protection of the amino group allows for the incorporation of glutamine derivatives into peptidomimetics, offering a way to create compounds with peptide-like properties while enhancing their pharmacological potential. This application is valuable in drug development for a wide range of diseases.

1.Synthesis and siderophore activity of albomycin-like peptides derived from N5-acetyl-N5-hydroxy-L-ornithine.
Dolence EK1, Lin CE, Miller MJ, Payne SM. J Med Chem. 1991 Mar;34(3):956-68.
N5-Acetyl-N5-hydroxy-L-ornithine (1), the key constituent of several microbial siderophores, has been synthesized in 23% yield overall from N-Cbz-L-glutamic acid 1-tert-butyl ester (6) derived from L-glutamic acid. Reduction of 6 to 7 and treatment with N-[(trichloroethoxy)carbonyl]-O-benzylhydroxylamine (8), and diethyl azodicarboxylate and triphenylphosphine followed by deprotection produced the protected N5-acetyl-N5-hydroxy-L-ornithine derivatives 11 and 12 in large quantities (10-20 g). Following alpha-amino and alpha-carboxyl deprotections of 11 and 12, EEDQ [2-ethoxy-N-(ethoxycarbonyl)-1,2-dihydroquinoline] mediated peptide coupling and final deprotection provided amino acid 1 and six albomycin-like peptides (20, 23, 25, 28, 35, and 36). The growth-promoting ability of each was evaluated with the siderophore biosynthesis mutant Shigella flexneri SA240 (SA 100 iucD:Tn5). These results indicate that substantial modification of the framework of peptide-based siderophores can be tolerated by microbial iron-transport systems.
2.Critical difference in chiral recognition of N-Cbz-D/L-aspartic and -glutamic acids by mono- and bis(trimethylammonio)-beta-cyclodextrins.
Rekharsky M1, Yamamura H, Kawai M, Inoue Y. J Am Chem Soc. 2001 Jun 6;123(22):5360-1.
3.Synthesis of beta- and gamma-fluorenylmethyl esters of respectively N alpha-Boc-L-aspartic acid and N alpha-Boc-L-glutamic acid.
al-Obeidi F1, Sanderson DG, Hruby VJ. Int J Pept Protein Res. 1990 Mar;35(3):215-8.
The orthogonal synthesis of N alpha-Boc-L-aspartic acid-gamma-fluorenylmethyl ester and N alpha-Boc-L-glutamic acid-delta-fluorenylmethyl ester is reported. This is a four-step synthesis that relies on the selective esterification of the side-chain carboxyl groups on N alpha-CBZ-L-aspartic acid and N alpha-CBZ-L-glutamic acid. Such selectivity is accomplished by initially protecting the alpha-carboxyl group through the formation of the corresponding 5-oxo-4-oxazolidinone ring. Following side-chain esterification, the alpha-carboxyl and alpha-amino groups are deprotected with acidolysis. Finally, the alpha-amino group is reprotected with the t-butyl-oxycarbonyl (Boc) group. Thus aspartic acid and glutamic acid have their side-chain carboxyl groups protected with the base-labile fluorenylmethyl ester (OFm) and their alpha-amino groups protected with the acid-labile Boc group. These residues, when used in conjunction with N alpha-Boc-N epsilon-Fmoc-L-lysine, are important in the formation of side-chain to side-chain cyclizations, via an amide bridge, during solid-phase peptide synthesis.
Online Inquiry
Verification code
Inquiry Basket